Abstract We describe multiwell assays for detecting the accumulation as well as the subsequent oxidation of 14
Measurement of cellular processes such as the uptake and oxidation of energy-rich substrates is important in cell biology. Often, phenotypes of metabolic abnormalities may transmit into in vitro systems with whole cells or enzymes isolated from the affected individual. It has been shown that primary skeletal muscle cells from type 2 diabetics as well as severely obese patients have reduced capacity to oxidize fatty acids compared with cells isolated from healthy controls (1) (2) (3) . Moreover, a recent investigation demonstrated correlations between different metabolic parameters, such as respiratory quotient dynamics, insulin sensitivity, O 2 consumption, body fat mass, plasma free fatty acids, and fatty acid oxidation measured in primary cells from the respective donor (4) . These findings call for accessible multiwell assays for the measurement of substrate uptake and oxidation.
Scintillation proximity assays (SPAs) designed to detect radioligand accumulation in adherent cell layers have been commercially available for more than a decade (e.g., Cytostar SPA and Scintiplate) and used for numerous applications (5-7), but there are few published studies of nutrient metabolism. We present results on the accumulation of radiolabeled fatty acids and deoxyglucose (DOG) in human cells grown on 96-well SPA plates monitored noninvasively in real time. Numerous protocols designed for the measurement of cellular metabolism use
Cell culture
Human myotubes. Satellite cells were isolated from vastus lateralis muscle by needle biopsy, split three to four times (12) , and cultured on 96-well plates with DMEM (5.5 mM glucose), 2% FCS, 2% Ultroser G, and penicillin/streptomycin (P/S) until 70-80% confluent. Myoblast differentiation to myotubes was then induced by changing medium to DMEM (5.5 mM glucose) including 2% FCS, 25 pM insulin, and P/S and continued for 4 days before preincubations were started. SGBS adipocytes. Preadipocytes were cultured on 96-well plates with growth medium consisting of DMEM/Nutrient Mix F12, 10% FCS (non-heat-inactivated), 8 mg/l biotin, 4 mg/l D-pantothenate, 2 mM L-glutamine, and P/S. Differentiation of confluent preadipocytes to adipocytes was initiated by washing the cells and adding serum-free growth medium supplemented with 10 mg/l human apo-transferrin, 0.2 nM triiodo-L-thyronine, 20 nM insulin, 100 nM cortisol, 500 mM IBMX, 25 nM dexamethasone, 1 mM rosiglitazone, 2 mM L-glutamine, and P/S for 4 days and then continued without IBMX, dexamethasone, and rosiglitazone for another 10 days.
Human hepatoma cell line. HepG2 cells were cultured on 96-well plates with MEM, 10% FCS, 1 mM sodium pyruvate, 100 mM nonessential amino acid mix, 2 mM L-glutamine, and P/S.
SPA
Radiolabeled substrates taken up and accumulated by adherent cells will be concentrated close to the scintillator embedded in the plastic bottom of each well; thus, they provide a stronger signal than the radiolabel dissolved in the medium alone (Fig. 1) . Influx (increased signal intensity) as well as efflux/catabolism (decreased signal intensity) can be monitored by the SPA system. Optimization of the specific radioactivity must be done empirically to find the lowest value providing acceptable signal-tobackground/noise values. SPA plates have counting efficiencies for cell-associated 14 Glucose uptake. Differentiated myotubes were preincubated for 24 h with 100 mM PA or 40 mM BSA (control) and then washed with PBS before incubation in medium containing [1- 14 C] D-DOG (2 mCi/ml) with or without insulin (1 mM).
For measurement of glucose or fatty acid uptake with the SPA technique, cells were added to 50 ml/well of radiolabeled medium and incubated (5% CO 2 atmosphere at 37jC) for 240-300 min. The increase in cell-associated radioactivity was measured in a six channel MicroBeta: Trilux scintillation counter (Perkin-Elmer) at several time points during incubation. Each well was counted for 30 s, giving a total time of counting one plate of only 8-9 min. Some empty wells were also added to 50 ml of radiolabeled medium to correct for the background. Finally, the cells were washed three times with PBS, harvested with 0.05 M NaOH (200 ml/well), and homogenized by ultrasonography. Protein was determined by either Coomassie reagent for myotubes or BC assay reagent for SGBS cells. A total of 100-125 ml of cell homogenate per sample was added to scintillation fluid and counted by conventional liquid scintillation.
Substrate oxidation assay
HepG2 cells or human myotubes were grown on standard 96-well tissue culture plates or 96-well CellBIND: tissue culture plates as described above. Any preincubation substances were added directly to the medium. Substrate oxidation was monitored by incubating cells with 14 C-labeled fatty acids, with subsequent capture of liberated 14 CO 2 . Substrate medium was made of DPBS supplemented with 10-20 mM HEPES and 1 mM L-carnitine, adjusted to pH 7.3, and added to 20 or 100 mM (1 mCi/ml) fatty acid (either OA or PA), and the cells were added at 50 ml/well. A 96-well filter plate (UniFilter: GF/B) was activated for capture of CO 2 by the addition of freshly made NaOH (1 M, 25 ml/well). The plate harboring the cells was clamped together with the filter plate, forming a "sandwich," with the following bottom-to-top order: cell plate/silicon gasket/inversed filter plate (Fig. 2) . The sandwich was placed in an incubator at 37jC, and substrate oxidation was allowed for 2-4 h. CO 2 produced from cellular respiration during incubation was continuously trapped in the filters. After incubation, the amounts of 14 CO 2 captured in the filters were monitored by the addition of scintillation fluid (e.g., OptiPhase Supermix or MicroScinti O; 50 ml/well). Radioactivity was counted in a scintillation counter for multiwell plates (e.g., MicroBeta: Trilux or TopCount from Perkin-Elmer). Capacity and linear range for CO 2 trapping were evaluated by adding acid (5 M H 2 SO 4 ) to medium containing increasing amounts of NaH 14 CO 3 dissolved in PBS on the 96-well plate (up to 1 mmol/well) with subsequent CO 2 capture for 5 h at room temperature.
Comparison with conventional substrate oxidation assay
Trapping of metabolized CO 2 was also monitored with a conventional method using HepG2 cells seeded in 12.5 cm 2 flasks and cultured to confluence. During measurement of OA oxidation, cells were incubated with DMEM supplemented with 20 mM [1-14 C]OA (1.1 mCi/ml), 1 mM L-carnitine, and 10 mM HEPES. The flasks were made airtight with rubber caps, and after 2 h, each flask was injected with 300 ml of phenylethylamine-methanol (1:1, v/v) through the rubber cap into a center well containing a folded filter paper. Subsequently, 300 ml of perchloric acid (1 M) was added to the cells, and the flasks were allowed to stand at room temperature to trap labeled CO 2 . The center wells with filters were transferred to separate counting tubes, scintillation fluid added and the samples counted in a b-counter.
Presentation of data and results
All values are reported as means 6 SEM. All experiments were performed with three to six parallel assays.
RESULTS
Long-chain fatty acid accumulation in human myotubes and SGBS adipocytes Figure 3 shows the time-and concentration-dependent increases in cell-associated [ 14 (Fig. 3A-D) there were small or no differences between the accumulation of PA, OA, and LA, they clearly accumulated less EPA at all concentrations tested. The processes governing fatty acid accumulation in myotubes also seemed saturated at the highest concentrations. The SGBS cells, however (Fig. 3E-H) , did not show signs of saturation, and there were no apparent differences between the uptake rates of the different fatty acids. SGBS adipocytes also displayed two to four times greater accumulation of all fatty acids compared with myotubes.
Moreover, we compared the amounts of cell-associated fatty acids after 4 h of incubation using the SPA method with the conventional technique of washing, harvesting, and scintillation counting of the dissolved cells. The correlations between the two methods were 0.93, 0.96, 0.97, and 0.95 for PA, OA, LA, and EPA, respectively.
Insulin-stimulated glucose uptake in human primary skeletal muscle cells Figure 4 shows the accumulation of [ 14 C]DOG/5.5 mM glucose in human myotubes with or without 1 mM insulin after preincubation with control medium (Fig. 4A) or 100 mM palmitate (Fig. 4B) . Preincubation with palmitate decreased the insulin-dependent portion of radiolabeled glucose uptake (Fig. 4C) . The lower panel illustrates the principles of the CO 2 trapping system. When a 14 C-labeled substrate is oxidized, the released CO 2 will be trapped in the alkaline suspension in the top filter.
In vitro measurement of cellular metabolismCapacity and linear range of 96-well CO 2 
trapping
The appliance for capturing metabolic CO 2 ( Fig. 2 ) was tested for capacity and linearity using NaH 14 CO 3 . Figure 5A shows the amount of 14 CO 2 trapped in the filters plotted against the total amount of NaH 14 CO 3 present on the lower 96-well plate. The amount of 14 CO 2 captured in the filters showed a linear relation with the total amount of CO 2 released (between 0 and 1 mmol), which covers the range of CO 2 expected to be produced by any cultured cell type.
Comparison of the multiwell assay with the conventional "flask" method
We compared our new method for trapping and quantification of 14 CO 2 with the conventional use of tissue culture flasks equipped with small cups. Similar amounts of 14 CO 2 were trapped with both methods after incubation of HepG2 cells with [ 14 C]OA (Fig. 5B) . The cells also grew equally well in both formats, as shown by measurement of cell protein (Fig. 5C ).
Acute dose response of a carnitine palmitoyl transferase-1 inhibitor
To further investigate the usefulness of the substrate oxidation method, we examined different conditions related to fatty acid metabolism. The mitochondrial import of longchain fatty acids for b-oxidation is controlled by carnitine palmitoyl transferase-1 (CPT1). HepG2 cells or human myotubes were incubated with increasing concentrations of the irreversible CPT1 inhibitor, etomoxir, and the amount of (Fig. 6) . This demonstrates that the multiwell substrate oxidation method can be used for compound screening and dose-response testing.
Long-term incubation of myotubes with a peroxisome proliferator-activated receptor d agonist
The peroxisome proliferator-activated receptor y agonist GW501516 may induce genes involved in the transport and oxidation of fatty acids in cells (13, 14) . We exposed myotubes to increasing concentrations of GW501516 for 3 days and then monitored the oxidation of [
14 C]OA. The oxidation was increased in a concentration-dependent manner up to 10 nM of the agonist (EC 50 ? 0.6 nM), with a maximum increase of ?2-fold compared with the control (Fig. 7A) . Preincubation with GW501516 increased cellassociated [ 14 C]OA similar to the oxidation (Fig. 7B) , although the relative effect was markedly smaller. 
DISCUSSION
We describe two multiwell in vitro assays for the detection of cellular uptake and oxidation of fatty acids and glucose. We have demonstrated the potential of the SPA technique for measurements of both fatty acid and glucose accumulation in muscle cells and SGBS adipocytes. The myotubes exhibit saturation, whereas the SGBS cells demonstrate a linear relationship between fatty acid concentration and cell-associated accumulation of radioactivity up to 200 mM concentration of fatty acids. Furthermore, the results obtained using the Cytostar-T: plates correlated very well with the total radioactivity monitored with conventional scintillation after solubilizing the cells.
The noninvasiveness of the SPA procedure allows continuous monitoring of the cells and thereby makes it feasible to study the accumulation as well as the efflux of cell-associated radiolabeled substrates. In addition to high throughput, the SPA approach will also be valuable for studies of primary cells, of which there might be a limited amount available, and for other cell systems that are time-consuming to grow and differentiate (e.g., SGBS cells and myotubes). The only limitations with the detection of substrate accumulation by Cytostar-T: plates are the need for the cells to be adherent to the plate bottom and the fact that the substrate has to be labeled with a suitable b-emitter (preferably 14 C or 3 H). An alternative approach for the measurement of substrate flux ex vivo/ in vitro is the use of positron autoradiography, in which the accumulation and, if applicable, secretion of b 1 -emitting tracers (e.g., 11 C or 18 F) can be followed noninvasively in tissue slices (15, 16) . This method elegantly In vitro measurement of cellular metabolismgenerates two-dimensional images of tracer distribution in the samples, but at the expense of low throughput and high cost.
Similar arguments presented as rationales for using SPA microplates to monitor nutrient accumulation in vitro also hold for our method for CO 2 trapping. We demonstrate the capture and quantification of 14 CO 2 produced from cells grown on standard 96-well tissue culture plates. This method uses an inverted multiwell filter plate immersed with an alkaline solution (NaOH), placed with the wells aligned on top of the plate encompassing the cells of interest. This CO 2 trap generates similar results compared with a conventional method of capturing CO 2 and has a long linear range, covering the expected amount of CO 2 produced by cells grown on 96-well plates. In addition, the described method enables the cells to be washed and harvested after incubation, thereby increasing the yield of data that can be obtained from the experiment. Our constructed CO 2 trap also allows the exchange of filter plates during experiments, making time-course measurements very feasible. To validate the appliance for detecting CO 2 trapping, myotubes and HepG2 cells were incubated with the irreversible CPT1 inhibitor etomoxir, which markedly inhibited fatty acid oxidation. Myotubes were also preincubated with the selective peroxisome proliferator-activated receptor y agonist GW501516, promoting a dose-dependent induction in 14 CO 2 produced from oxidized [
14 C]OA. Comparison between markers of disease in vivo and defects/changes in cellular metabolism in vitro has the potential to be a fruitful strategy for studies of metabolic abnormalities. The exploration of this field of research has to a large extent been slowed by timeconsuming and cumbersome methods for studying nutrient handling. In this article, we have described two principles for the detection of substrate accumulation and oxidation that may help to overcome some of these obstacles.
